These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 6817447

  • 21. [Studies on the usefulness of double filtration plasmapheresis in a hemophilia A patient with anti-factor VIII antibody (inhibitor)].
    Okubo S, Ikuma T, Hamaguchi Y, Yasunaga K.
    Rinsho Ketsueki; 1985 May; 26(5):701-8. PubMed ID: 3932716
    [No Abstract] [Full Text] [Related]

  • 22. Clinical experience with polyelectrolyte-fractionated porcine factor VIII concentrate in the treatment of hemophiliacs with antibodies to factor VIII.
    Kernoff PB, Thomas ND, Lilley PA, Matthews KB, Goldman E, Tuddenham EG.
    Blood; 1984 Jan; 63(1):31-41. PubMed ID: 6418234
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. What can we learn from the immune response to human factor VIII in a mouse model of hemophilia A?
    Reipert BM, Schwarz HP.
    Thromb Haemost; 2002 Aug; 88(2):374-5. PubMed ID: 12195723
    [No Abstract] [Full Text] [Related]

  • 26. Induction of tolerance using porcine factor VIII.
    Hay CR, Laurian Y.
    Vox Sang; 1996 Aug; 70 Suppl 1():68-9. PubMed ID: 8869473
    [No Abstract] [Full Text] [Related]

  • 27. HLA antigens and factor VIII antibody in classic hemophilia. European study group of factor VIII antibody.
    Frommel D, Allain JP, Saint-Paul E, Bosser C, Noël B, Mannucci PM, Pannicucci F, Blombäck M, Prou-Wartelle O, Muller JY.
    Thromb Haemost; 1981 Dec 23; 46(4):687-9. PubMed ID: 6800049
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Antibodies to factor VIII. 3. Characterization of the immune response to iso- and heteroantigens in hemophilia A.
    Allain JP, Vedrenne J, Frommel D.
    Pathol Biol (Paris); 1973 Nov 23; 21():Suppl:76-9. PubMed ID: 4128454
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Factor VIII inhibitors.
    Gilles JG, Jacquemin MG, Saint-Remy JM.
    Thromb Haemost; 1997 Jul 23; 78(1):641-6. PubMed ID: 9198231
    [No Abstract] [Full Text] [Related]

  • 33. Antigenic differences among bovine and porcine Factor VIII concentrates.
    Edson JR, Swinehart CD.
    Am J Clin Pathol; 1976 Jun 23; 65(6):957-63. PubMed ID: 59540
    [Abstract] [Full Text] [Related]

  • 34. [Hemophilia A with inhibitor].
    Takahashi I.
    Ryoikibetsu Shokogun Shirizu; 1998 Jun 23; (21 Pt 2):498-501. PubMed ID: 9833554
    [No Abstract] [Full Text] [Related]

  • 35. [Safe and cost-conscious supply of factor-VIII-deficient Swiss hemophiliacs with AHF preparations].
    Stampfli K.
    Ther Umsch; 1977 Oct 23; 34(10):717-24. PubMed ID: 918896
    [No Abstract] [Full Text] [Related]

  • 36. Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors.
    Reipert BM, van Helden PM, Schwarz HP, Hausl C.
    Br J Haematol; 2007 Jan 23; 136(1):12-25. PubMed ID: 17222196
    [Abstract] [Full Text] [Related]

  • 37. [Circulating anticoagulants during hemophilia].
    Josso F, Cosson A, Gazengel C, Allain JP.
    Rev Fr Transfus; 1972 Dec 23; 15(4):281-98. PubMed ID: 4659598
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The clinical use of porcine factor VIII.
    Kernoff PB.
    Prog Clin Biol Res; 1990 Dec 23; 324():47-56. PubMed ID: 2106692
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.